HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple endocrine neoplasias type 2A and thyroid medullary carcinoma: an interdisciplinary challenge.

Abstract
The diagnosis and treatment of multiple endocrine neoplasias type 2A (MEN 2A) requires interdisciplinary management. The association of RET proto-oncogene mutations and medullary thyroid carcinoma (MTC) in children is well-known, but the optimal timing for elective surgery is controversial. Besides the risk of MTC, associated anomalies like hyperparathyroidism have to be considered. We report the results of molecular genetic investigations, the pentagastrin stimulation test, pre- and postoperative staging, and histologic examinations of four children who had a positive family history for MEN 2A. Histologic specimens of the removed thyroid glands showed MTC in all four cases. The patients had an uneventful postoperative clinical course. In view of the recent literature and our patients' results, we suggest a concept for diagnostic strategy and timing of the elective thyroidectomy.
AuthorsFrank-Martin Haecker, Daniel Oertli, Stefanie Gissler, Urs Zumsteg, Pierino Avoledo, Dietrich von Schweinitz
JournalPediatric surgery international (Pediatr Surg Int) Vol. 19 Issue 1-2 Pg. 62-4 (Apr 2003) ISSN: 0179-0358 [Print] Germany
PMID12721726 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Carcinoma, Medullary (complications, genetics, surgery)
  • Child
  • Female
  • Humans
  • Male
  • Multiple Endocrine Neoplasia Type 2a (complications, genetics, surgery)
  • Mutation
  • Neoplasm Staging
  • Proto-Oncogene Mas
  • Thyroid Neoplasms (complications, genetics, surgery)
  • Thyroidectomy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: